SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-023654
Filing Date
2020-05-08
Accepted
2020-05-08 17:12:33
Documents
5
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A etnb-defa14a_20200622.htm DEFA14A 32784
2 GRAPHIC gt13opkfevz5000004.jpg GRAPHIC 10772
3 GRAPHIC gt13opkfevz5000003.jpg GRAPHIC 16064
4 GRAPHIC gt13opkfevz5000002.jpg GRAPHIC 61239
5 GRAPHIC gt13opkfevz5000001.jpg GRAPHIC 39898
  Complete submission text file 0001564590-20-023654.txt   210563
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39122 | Film No.: 20861697
SIC: 2834 Pharmaceutical Preparations